WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

ANALYTICAL METHOD DEVELOPMENT AND VERIFICATION OF DAPAGLIFLOZIN RELATED SUBSTANCES ESTIMATION IN DAPAGLIFLOZIN TABLETS BY RP-HPLC

Dr. Akuthota Ashok Kumar*, Bembadi Mukund Reddy, Bheemi Reddy Ashok Reddy and Dr. Rajesh Vooturi

ABSTRACT

The objective of the research is to develop a simple, sensitive, accurate, precise, and linear Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) Related Substances (RS) method for the quantification of Dapagliflozin related substances (degradants) and verify in Dapagliflozin tablets. The optimized method uses a reverse phase Agilent poroshell 120 EC- C18 column, (250 X 4.6 mm; 2.7μm), part number 690975-902, mobile phase-A consisting of 0.05% OPA buffer: Methanol in the proportion of 90:10 v/v, mobile phase-B consisting of water: acetonitrile in the proportion of 30:70 v/v, flow rate of 0.9 ml/min, injection volume of 5 µL, and detection wavelength of 225 nm. The developed method eluted Dapagliflozin at about 10 min by gradient elution mode. Dapagliflozin (unknown impurity) exhibited linearity in the range LOQ of 0.05% (0.25 μg/ml) to 150% (1.6μg/ml) considering the unknown impurity specification limit as 0.2%. The precision is exemplified by relative standard deviation of 2.3% and 2.5% for single maximum known impurity and total impurities. Percentage individual recovery was found to be in the range of 98.86 and 101.96 during accuracy studies. Specificity established non-interference of blank, placebo, known impurities with the degradants and Dapagliflozin peak along with the resolution between the known impurities and the degradants. Peak purity passed for Dapagliflozin peak in diluted standard, as such sample, spiked sample and forced degradation sample, indicating that method developed is a stability-indicating and hence this method can be explored for the routine analysis of Dapagliflozin related substances quantification in Dapagliflozin tablets in various pharmaceutical industries.

Keywords: HPLC, Dapagliflozin Tablets, Related substances, Impurities, Degradants.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More